The American Pharmacists Association (APhA) commends the U.S. Department of Health and Human Services (HHS) for announcing that they will ensure that patients can continue to get COVID-19–related care from their pharmacists. APhA is grateful that HHS listened to the concerns of APhA and others in the pharmacy community in expressing a need for HHS to clarify the role of pharmacists and pharmacy teams when the public health emergency expires on May 11, 2023.

The American Pharmacists Association (APhA) applauds the introduction of the Drug Price Transparency in Medicaid Act, which would reign in PBMs’ unfair and anticompetitive business practices that are harming the viability of our nation’s pharmacies.

WASHINGTON, DC— Today the American Pharmacists Association (APhA) and the National Alliance of State Pharmacy Associations (NASPA) released the fourth installment of the Pharmacy Workplace and Well-being Reporting (PWWR) trends and findings report series.